A model of irradiated cell survival probability based on cell-cycle regulation of an avascular tumor is developed. It is shown, that for high doses as used in hypofractionated regimens the conventional linear quadratic (LQ) model grossly underestimate cell survival. The surviving fraction of tumor cells in hypoxic and normoxic conditions is calculated as a function of dose for an equivalent tumor biological effective dose. The usefulness of an empirical LQ-linear model which is obtained from experimental data at high doses is investigated and the corresponding survival probabilities are compared in normoxic and hypoxic conditions. It has been found that the LQ model with hypoxia and the LQ-linear model partially coincide at high doses. Cell-cycle regulations have been found to considerably influence time-resolved response of cell populations to irradiation. In particular, if using LQ instead of LQ-linear model for high doses, a recovery of the population may be undiscovered.
Introduction
This work is motivated by progress in radiation oncology which -in hypofractionation treatments like stereotactic body radiosurgery (SBRT) -delivers larger than conventional doses per fraction. In a previous work we developed a cell-cycle based multi-scale framework to model the growth and the treatment, e.g. by external radiotherapy, of avascular tumors [1] . In empirical and theoretical investigations the use of linear-quadratic (LQ) model is shown to be a questionable approximation for large doses [2] . Despite of these facts the LQ model remains widely used tool for treatment planning in radiation oncology. Recently, an empirical extension of LQ model for large dose has been proposed [3] . We incorporate this approach, called LQ-linear, into our cell-cycle model and calculate the cell survival probability S(D) as a function of dose D in hypofractionated regimen. We compare the outcomes to predictions of the traditional LQ radiation model for different avascular tumor types including prostate and head & neck tumor.
Methods

Avascular tumor model
In [1] , a multi scale model for avascular tumors was introduced which includes cell cycle dynamics. We briefly review the model in this subsection. The basic idea is that a typical tumor consists of proliferating cells (G 1 , S, G 2 , M phase) and cells which are quiescent (cells in the G 0 -phase). The cell cycle contains numerous checkpoints that allow the cell to check for and repair DNA damage, as well as to control or halt cycle progression. For instance, at the restriction (R) checkpoint late in the G 1 phase the cell either commits to division and progress to the S phase or exits the cell cycle and enters the quiescent state, i.e. G 0 phase. Cells that fail to repair DNA damage, e.g. caused by radiation, induce apoptosis at the G 2 /M checkpoint.
In [1] , the transition of cells from one phase into another is governed by probabilistic measures. Starting from an initial distribution of phase populations, it was assumed that all newly generated daughter cells (M) become either active (G 1 ) or quiescent (G 0 ) with different probabilities depending on nutrient distribution. In particular, for insufficient oxygen partial pressure the cell becomes quiescent, but can re-enter the cycle within a time interval in case conditions change to normoxic. For chronic hypoxia, however, the cell dies, becomes necrotic and will be removed after a defined lysis time. In the simulation the cell cycle duration was assumed to be T=36h and a time step of ΔT=1h has been chosen. An avascular tumor consists of motile cells that can proliferate as well as migrate, and thus the spatial aspects seem to be crucial in their theoretical modeling. The multi scale formulation in [1] is based on a discrete approach for modeling spatial development of cell populations. A fixed cellular lattice of sites corresponding to either a collection of biological cell or a vacant site is used. Each lattice site may host 10 4 biological tumor cells, at maximum. The state of each tumor cell is characterized by a vector variable describing the position of the cell on the lattice, cell's internal biological state, which incorporates its position in the cell cycle, its interaction with the local biological environment, e.g. nutrients or oxygen, its sensitivity to radiation, etc.
If the number of tumor cells in a lattice site exceeds the maximum allowed number, cells are able to proliferate into a nearby lattice vacant site, i.e. a site containing less than the maximum allowed number of cells. In general, this proliferation might depend on the levels of nutrients, oxygen and waste products at any given point. The model investigated here restricts itself to the movement of cells on the lattice to a neighborhood site. It is governed by oxygen partial pressure which increases monotonically with the distance from tumor center. Hypoxic, normoxic or aerobic conditions leads to tumor death, steady state and infinite growth, respectively.
Measures for tumor survival
Denoting the fraction of tumor cells that survives treatment by n(t) and the initial number of cells by n 0 the most general and frequently used definition of survival probability S(D) as function of radiotherapeutic dose D reads:
Frequently, in clinical practice, the Biological Effective Dose (BED), is used to compare different treatment strategies [2] : (2) where α is a cellular radiosensitivity that vary with the type of tissue being radiated. To complete the expression for BED, one needs a model for the survival fraction S(D).
Here we restrict our self on the most commonly used models, namely empirical models derived from clinical data and stochastic models, potentially including cell cycle.
The most prominent empirical model is the linearquadratic model (LQ) [2, 4] :
Here β is a second cellular radiosensitivity that varies with the type of tissue being irradiated. In clinical practice, total dose D=Nd is given in N fractions, each of dose d. The fraction of surviving cells becomes:
The empirical LQ formula -although derived from clinical data -does not adequately fit all cell survival experiments [5] . The LQ equation closely fits most of data for doses up to 6 Gy, but it is incompatible with experimental log-linear dose-response curves which are characterized by very broad shoulders, i.e. small values of tumor radiosensitivity parameters α/β [3] . In fact, while the LQ curve for large doses continues to bend the experimental results are observed to become linear beyond some high dose value denoted by d T . Consequently, for these tumor types and for high doses, the LQ model overestimates the magnitude of cell kill, or, equivalently, underestimates the surviving fraction S(D).
In order to study hypofractionation treatments with larger than conventional doses d per fraction, Eq. (3) for doses d>d T will be replaced by the following linear function which defines the LQ-linear (LQ-L) model [3] :
The new parameter γ = α+βd T is the slope of the log-linear dose curve S(D) at d=d T , which is the onset of the linearity as shown in Fig. 2 . In [3] , d T = 2α/β has been deduced as a good approximation from analysis of measured survival fractions for different tumor cells. 
If d>d T and the LQ-linear model is used the dose d has to be recalculated using Eq. (5). We note that many other extensions to the LQ model have been developed in an attempt to account for temporal phenomena such as repair of sublethal damage, repopulation and reoxygenation which can occur during lengthy fractionated regimens [11] . For (extremely) hypofractionated regimens repopulation will likely not be an issue. Nevertheless, the extensions could be applied in an identical manner. Cancer cell kill due to radiation is in fact a stochastic process [6] . Poisson or binomial distribution can be used for the tumor control probability. Here probabilistic birth and death events are included through stochastic cell-cycle regulations [1] . While the cell number n(t) is continuously recorded, the cell kill due to radiation is modeled as a stochastic process governed by the survival probability S(D) as given by (4) and (5) . Survival rate S(D) including cell cycle kinetics is than calculated using (1). It has been pointed out in [7] , that tissue with low oxygen level is much more resistive to radiation. Therefore, we introduced the oxygen modification factor (OMF) to the radiosensitivity coefficients: 
where pO 2 is the partial oxygen pressure and OER the oxygenation enhancement ratio. We use m=k=3 and note that in this case OMF < 1. An appropriate and consistent scaling of the radiosensitivity parameters in (3) and (5) requires replacing α and β by αOMF and βOMF 2 , respectively, which means reduced sensitivity in hypoxic environments. In addition, it has been suggested by [8] that cell cycle regulation and anti-growth signals such as hypoxia can play an important role in the reduction of response to radiation. That is, for cells within the S-or G 0 -phases of the cell cycle, or given low levels of oxygenation, a higher level of radio-resistance occurs. The sensitivity parameters have been chosen differently for S-or G 0 -phases by using OER p =3, as shown in Tab.1 [9] . Table 1 : Radiation coefficients of cell phases as a function of oxygen enhancement ratio (OER p ).
In summary, despite of the approach chosen to calculate the surviving fraction, according to Eq. (1), S(D) remains the central quantity when calculating BED. It is the purpose of this paper to compare standard and hypofractionated treatments for several tumor tissues at a constant BED level including stochastic nature cell cycle, radiation for various fraction numbers N, and the LQ and LQ-linear models.
Results
It is well known, that avascular tumors are finite in size and develop a necrotic core which is surrounded by a rim of proliferating cells. Our multiscale cell-cycle model generates in normoxic conditions stationary solutions, shown in Figure 3 . Despite of stochastic fluctuations the number of cells remains constant once balance is achieved between oxygen proliferation from the surrounding environment and the complex interactions in the cell cycle. The averaged radius formed by necrotic cells is smaller than for total number of cell proving that our model produces a viable rim of proliferating cells around the necrotic core. These solutions are the starting point for the subsequent radiotherapy treatment. Although many investigators question the applicability of the LQ model at doses higher than d=6Gy, e.g. [5] , others hypothesize that the LQ model is appropriate for use in analyzing hypoxic cell survival data up to an even higher dose range [10] . We test this hypothesis comparing the LQ and the LQ-linear model predictions for S(D) in normoxic and hypoxic surrounding implemented via the oxygen factor OMF. Figures 4 and 2 (the later assumes OMF=1) show that low oxygen levels essentially shift the S(D) curve to higher doses. In hypoxia LQ and LQ-linear predicts comparable values for S(D). This is a consequence of fixing the slope of the linear term by d T =2α/β which is justified by experimental data. In that sense a LQ expression accounting for hypoxia could be a good qualitative replacement for the LQ-linear model at high doses, e.g. appropriate description of cell survival measured data. The values of the radiosensitivity coefficientsα,β are taken from [12, 13] . Equal BED and equal dose condi-
tions are compared for two prostate and one head & neck cancer cells. For the chosen BED the dose is very high and S(D) decreases rapidly within 22h. However, due to the cell cycle time of T=36h cell-cycle is not finished allowing the population to recover. All cells die later on because cell generation, natural apoptosis and oxygenation levels are not in balance any more. The comparison of survival probability S(D) at constant dose reveals potential consequence of underestimating the survival ratio, i.e. using LQ (instead of LQ-linear) model at high dose in normoxic conditions. For late responding (to the therapy) prostate cancer which has high repair capacity the cell population n(t) predicated by using LQlinear model is decimated within the 22h, recover and continues to develop in time. This is not observed for acute responding head-and-neck cancer which possesses low repair capacity. In this case the α/β ratio is high and the oxygen level low, thus there is no difference between LQ and LQ-linear formalism. However, cell-cycle regulations manifest themselves in a time shift of populations.
Conclusion
We applied the BED concept to late (prostate) and acute (head-and-neck) responding cancer tissues and calculate cell survival S(D) using cell-cycle kinetics. We implemented conventional LQ and LQ-linear formalism. Hypoxic conditions in the cell cycle are accounted for by an oxygen reduction factor. When respecting equal BED, equivalent doses for (hypo-) fractions calculated using LQ are lower than from LQlinear formalism. Cell survival decreases, specifically for late responding cancer. Hypoxia influence cell survival probability depending on radiation parameters. For a specified dose interval, LQ with hypoxia accounted for by an oxygen enhancement ratio is comparable with LQlinear model. Based on our new multiscale cell-cycle model we examined the role of tumor cell cycle regulations in external radiotherapy. We compared LQ versus extended LQlinear formalism and calculated cell survival probability. We found that (i) cell cycle regulation is an important determinant of sensitivity to ionizing radiation and (ii) antigrowth signals such as hypoxia play a crucial role in the time resolved response of cell populations to irradiation.
